NCT00007943View on ClinicalTrials.gov

Gemcitabine in Treating Patients With Advanced Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 1, 2000

Primary Completion Date

February 27, 2001

Study Completion Date

February 27, 2001

Conditions
Colorectal Cancer
Interventions
DRUG

gemcitabine hydrochloride

Trial Locations (1)

27157-1082

Comprehensive Cancer Center of Wake Forest University Baptist Medical Center, Winston-Salem

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT00007943 - Gemcitabine in Treating Patients With Advanced Colorectal Cancer | Biotech Hunter | Biotech Hunter